van Duin, D., Doi, Y., The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence 8:4 (2016), 460–469.
Rodriguez-Villalobos, H., Glupczynski, Y., Emergence and dissemination of multi-resistant Gram negative Enterobacteriaceae: lessons to be learnt from local and national surveillance programs in Belgium. Acta Clinica Belgica 70:1 (2015), 1–10.
Doi, Y., Paterson, D.L., Carbapenemase-producing Enterobacteriaceae. Semin Respir Crit Care Med 36:1 (2015), 74–84.
Queenan, A.M., Bush, K., Carbapenemases: the Versatile β-Lactamases. Clin Microbiol Rev 20:3 (2007), 440–458.
Martínez-Martínez, L., González-López, J.J., Carbapenemases in Enterobacteriaceae: types and molecular epidemiology. Enferm Infecc Microbiol Clin 32:4 (2014), 4–9.
Grundmann, H., Glasner, C., Albiger, B., et al. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. The Lancet Infectious Diseases 17:2 (2017), 153–163.
Schwaber, M.J., Klarfeld-Lidji, S., Navon-Venezia, et al. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 52:3 (2008), 1028–1033.
Cantón, R., Akóva, M., Carmeli, Y., et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clinical Microbiology and Infection 18:5 (2012), 413–431.
Antibiotic resistance threats in the United States, 2013. Centers for Disease Control and Prevention. [En ligne] https://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf. Accessed on August 10, 2017.
van duin, D., Carbapenem-resistant Enterobacteriaceae: what we know and what we need to know. Virulence 8:4 (2017), 379–382.
Tzouvelekis, L.S., Markogiannakis, A., Psichogiou, M., et al. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 25:4 (2012), 682–707.
WHO | Antimicrobial resistance: global report on surveillance 2014. World Health Organization. [En ligne] http://www.who.int/drugresistance/documents/surveillancereport/en/Accessed on September 14, 2017.
Djordjevic, Z.M., Folic, M.M., Folic, N.D., et al. Risk factors for hospital infections caused by carbapanem-resistant Acinetobacter baumannii. J Infect Dev Ctries 10:10 (2016), 1073–1080.
Vaze, N.D., Emery, C.L., Hamilton, R.J., et al. Patient Demographics and Characteristics of Infection with Carbapenem-Resistant Acinetobacter baumannii in a Teaching Hospital from the United States. Advances in Infectious Diseases 3:1 (2013), 10–16.
Dizday, M., Tunccan, O.G., Sezer, B.E., et al. Nosocomial imipenem-resistant Acinetobacter baumannii infections: Epidemiology and risk factors. Scand J Infect Dis 42:10 (2010), 741–746.
Djahmi, N., Dunyach-Remy, C., Pantel, A., et al. Epidemiology of Carbapenemase-Producing Enterobacteriaceae and Acinetobacter baumannii in Mediterranean Countries. Biomed Res Int, 2014, 2014, 305784.
Munoz-Price, L.S., Poirel, L., Bonomo, R.A., et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. The Lancet Infectious Diseases 13:9 (2013), 785–796.
López-Cerero, L., Almirante, B., Epidemiology of infections caused by carbapenemase-producing Enterobacteriaceae: reservoirs and transmission mechanisms. Enferm Infecc Microbiol Clin 32:4 (2014), 10–16.
Nordmann, P., Poirel, L., The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clinical Microbiology and Infection 20:9 (2014), 821–830.
Huang, T.D., Bogaerts, P., Berhin, C., et al. Rapid emergence of carbapenemase-producing Enterobacteriaceae isolates in Belgium. Euro Surveill, 16(26.), 2011.
Albiger, B., Glasner, C., Struelens, M.J., et al. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015. Euro Surveill, 20(45.), 2015.
Huang, T.D., Berhin, C., Bogaerts, P., et al. Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium. J Antimicrob Chemother 68:8 (2013), 1832–1837.
Huang, T.D., Bogaerts, P., Berhin, C., et al. Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in Belgium from September to November 2015. Euro Surveill, 22(19), 2017, 30530.
Rodriguez Villalobos, H., Bogaerts, P., Glupczynski, Y., et al. Trends in production of extended-spectrum beta-lactamases among Enterobacteriaceae of clinical interest: results of a nationwide survey in Belgian hospitals. J Antimicrob Chemother 66:1 (2011), 37–47.
Charlson Comorbidity Index (CCI). MDCalc–Medical calculators, equations, equations, algorithms, and scores. 2017. [En ligne] https://www.mdcalc.com/charlson-comorbidity-index-cci. Accessed on December 17, 2019.
Gutiérrez-Gutiérrez, B., Salamanca, E., de Cueto, M., et al. Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study. The Lancet Infectious Diseases 17:7 (2017), 726–734.
van Duin, D., Perez, F., Rudin, S.D., et al. Surveillance of Carbapenem-Resistant Klebsiella pneumoniae: Tracking Molecular Epidemiology and Outcomes through a Regional Network. Antimicrob Agents Chemother 58:7 (2014), 4035–4041.
Guh, A.Y., Bulens, S.N., Mu, Y., et al. Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013. JAMA 314:14 (2015), 1479–1987.
Dautzenberg, M.J., Wekesa, A.N., Gniadkowski, M., et al. The association between colonization with carbapenemase-producing enterobacteriaceae and overall ICU mortality: an observational cohort study. Crit Care Med 43:6 (2015), 1170–1177.
Rihani, D.S., Wallace, M.R., Sieger, B.E., et al. Over-treatment of carbapenemase-producing Enterobacteriaceae. Scan J Infect Dis 44:5 (2012), 325–329.
Palacios-Baena, Z.R., Oteo, J., Conejo, C., et al. Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain. J Infect 72:2 (2016), 152–160.
De Geyter, D., Blommaert, L., Verbraeken, N., et al. The sink as a potential source of transmission of carbapenemase-producing Enterobacteriaceae in the intensive care unit. Antimicrob Resist Infect Control, 6, 2017, 24.
Morril, H.J., Pogue, J.M., Kaye, K.S., et al. Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections. Open Forum Infect Dis 2:2 (2015), 1–15.
